SCHEMBL1941841

SCHEMBL1941841

COc1ccc(CC(C#N)c2noc3cc(OC)ccc23)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 1/20 0.36
ACHE P22303 1/20 0.36
TLR4 O00206 1/20 0.35
XDH P47989 1/20 0.35
NLRP3 Q96P20 1/20 0.35
CHRNA7 P36544 2/20 0.35
HTR3A P46098 2/20 0.35
CYP2D6 P10635 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C19 P33261 1/20 0.35
LDHA P00338 1/20 0.35
MAOB P27338 2/20 0.34
MEN1 O00255 2/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
KMT2A Q03164 2/20 0.34
CASP3 P42574 1/20 0.34
SENP8 Q96LD8 1/20 0.34
SENP7 Q9BQF6 1/20 0.34
SENP6 Q9GZR1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2200450 0.80 ESR1 (0.50) XDHCYP2D6CYP2C19MEN1NPC1
SCHEMBL2202861 0.79 ESR1 (0.50) CYP1A2CYP2C19MEN1KMT2A
SCHEMBL5176224 0.78 TSHR (0.39) SLC6A4CYP2D6CYP1A2CYP2C19LDHA
SCHEMBL2388897 0.76 MAP2K4 (0.43) SLC6A4CYP2D6CYP1A2CYP2C19LDHA
SCHEMBL15653285 0.74 ADRB2 (0.44) CYP2C19MEN1KMT2ATP53
SCHEMBL2199591 0.72 ESR1 (0.45) CYP1A2CYP2C19MEN1KMT2A
SCHEMBL19951523 0.71 ALDH1A1 (0.61) SLC6A4CYP2D6CYP1A2CYP2C19LDHA
SCHEMBL2200446 0.70 ESR1 (0.43) CYP2D6CYP1A2CYP2C19MAOBMEN1
SCHEMBL1940345 0.70 ACHE (0.45) ACHECHRNA7HTR3ACYP2D6MAOB
SCHEMBL1390619 0.68 PTGS2 (0.48) CYP1A2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173679-B2 Indazoles, benzisoxazoles and benzisothiazoles and their use as estrogenic agents LABORATOIRE THERMAMEX (MC) 2012-05-08 US disclosed
US-20110237624-A1 INDAZOLES, BENZISOXAZOLES AND BENZISOTHIAZOLES AND THEIR USE AS ESTROGENIC AGENTS LABORATOIRE THERAMEX (MC) 2011-09-29 US disclosed
US-7977364-B2 Indazoles, benzisoxazoles and benzisothiazoles and their use as estrogenic agents LABORATOIRE THERMAMEX (MC) 2011-07-12 US disclosed
EP-1812404-B1 INDAZOLES, BENZISOXAZOLES AND BENZISOTHIAZOLES AND THEIR USE AS ESTROGENIC AGENTS THERAMEX (MC) 2011-06-15 EP disclosed
US-20090023779-A1 Indazoles, benzisoxazoles and benzisothiazoles and their use as estrogenic agents LABORATOIRE THERAMEX (FR) 2009-01-22 US disclosed
EP-1647549-A1 Indazoles, benzisoxazoles and benzisothiazoles as estrogenic agents LABORATOIRE THERAMEX (MC) 2006-04-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090023779-A1 Indazoles, benzisoxazoles and benzisothiazoles and their use as estrogenic agents ESR1, ESR2, GPER1 SLC6A4 3025/4885ACHE 1147/4885TLR4 1278/4885
US-20110237624-A1 INDAZOLES, BENZISOXAZOLES AND BENZISOTHIAZOLES AND THEIR USE AS ESTROGENIC AGENTS ESR1, ESR2, GPER1 SLC6A4 3025/4885ACHE 1147/4885TLR4 1278/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.